Related Experiment Videos
Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres.
C Sturesson1, P Artursson, R Ghaderi
1Department of Polymer Technology, Royal Institute of Technology, S-100 44, Stockholm, Sweden.
Summary
Developing effective rotavirus vaccines requires stable microsphere formulations. Vortex mixing offers a robust method for creating poly(lactide-co-glycolide) microspheres with formaldehyde-inactivated rotavirus particles (FRRV), retaining antigenicity for robust immune responses.
Area of Science:
- Biotechnology
- Vaccine Development
- Materials Science
Background:
- Poly(lactide-co-glycolide) (PLG) microspheres are promising for vaccine delivery.
- Incorporating sensitive antigens like formaldehyde-inactivated rotavirus particles (FRRV) into PLG microspheres requires optimized formulation techniques.
- Ensuring antigen stability and controlled release is crucial for vaccine efficacy.
Purpose of the Study:
- To develop and optimize two small-scale double emulsion techniques for encapsulating FRRV into PLG microspheres.
- To compare the effects of high-speed homogenization versus vortex mixing on microsphere characteristics and FRRV release.
- To evaluate the immunogenicity of FRRV-loaded PLG microspheres in vivo.
Main Methods:
- Developed two double emulsion methods for FRRV encapsulation in PLG.
- Investigated high-speed homogenization and vortex mixing for the second emulsification step.
- Characterized microsphere size, entrapment efficiency, and in vitro FRRV release.
- Assessed serum IgG antibody response in mice post-immunization via ELISA.
Main Results:
- Vortex mixing yielded a stable double emulsion, unlike high-speed homogenization.
- Both methods produced microspheres in the 1-10 micrometer range.
- The vortex technique demonstrated greater robustness and predictability compared to homogenization.
- PLG-FRRV microspheres elicited an IgG antibody response comparable to free FRRV, indicating retained antigenicity.
Conclusions:
- Vortex mixing is a robust and suitable method for preparing PLG microspheres containing FRRV.
- The antigenicity of FRRV is maintained during encapsulation using the optimized vortex technique.
- PLG-FRRV microspheres represent a viable formulation for rotavirus vaccination, eliciting a strong immune response.